Denali Therapeutics Stock Price on December 16, 2022
| DNLI Stock | USD 16.60 0.22 1.31% |
Below is the normalized historical share price chart for Denali Therapeutics extending back to December 08, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Denali Therapeutics stands at 16.60, as last reported on the 19th of April, with the highest price reaching 16.95 and the lowest price hitting 16.54 during the day.
If you're considering investing in Denali Stock, it is important to understand the factors that can impact its price. We consider Denali Therapeutics not too volatile. Denali Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0152, which denotes the company had a 0.0152% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Denali Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Denali Therapeutics' Mean Deviation of 3.29, downside deviation of 4.42, and Coefficient Of Variation of 196441.22 to check if the risk estimate we provide is consistent with the expected return of 0.0918%.
As of now, Denali Therapeutics' Stock Based Compensation is increasing as compared to previous years. The Denali Therapeutics' current Stock Based Compensation To Revenue is estimated to increase to 0.63, while Total Stockholder Equity is projected to decrease to under 712.9 M. . The Denali Therapeutics' current Price Earnings To Growth Ratio is estimated to increase to 0.36, while Price To Sales Ratio is projected to decrease to 8.47. Denali Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of December 2017 | 200 Day MA 21.1156 | 50 Day MA 19.1906 | Beta 1.331 |
Denali |
Sharpe Ratio = 0.0152
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | DNLI | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.05 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Denali Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Denali Therapeutics by adding it to a well-diversified portfolio.
Price Book 2.4648 | Enterprise Value Ebitda (8.66) | Price Sales 7.6878 | Shares Float 120.2 M | Wall Street Target Price 41.19 |
Denali Therapeutics Valuation on December 16, 2022
It is possible to determine the worth of Denali Therapeutics on a given historical date. On December 16, 2022 Denali was worth 28.66 at the beginning of the trading date compared to the closed value of 28.69. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Denali Therapeutics stock. Still, in general, we apply an absolute valuation method to find Denali Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Denali Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Denali Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 30.49 | 30.67 | 28.67 | 29.03 | 681,000 | |
12/16/2022 | 28.66 | 29.02 | 27.42 | 28.69 | 2,205,200 |
| 28.75 | 29.14 | 26.21 | 26.28 | 722,800 |
| Backtest Denali Therapeutics | | | Denali Therapeutics History | | | Denali Therapeutics Valuation | Previous | Next |
Denali Therapeutics Trading Date Momentum on December 16, 2022
| On December 19 2022 Denali Therapeutics was traded for 26.28 at the closing time. The top price for the day was 29.14 and the lowest listed price was 26.21 . The trading volume for the day was 722.8 K. The trading history from December 19, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 8.40% . The overall trading delta against the current closing price is 3.42% . |
Denali Therapeutics Fundamentals Correlations and Trends
By evaluating Denali Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Denali Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Denali financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Denali Therapeutics Stock history
Denali Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Denali is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Denali Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Denali Therapeutics stock prices may prove useful in developing a viable investing in Denali Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 137.4 M | 86.7 M | |
| Net Loss | -293.4 M | -278.7 M |
Denali Therapeutics Quarterly Net Working Capital |
|
Denali Therapeutics Stock Technical Analysis
Denali Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Denali Therapeutics Period Price Range
Low | December 16, 2022
| High |
28.66 | 28.69 |
Denali Therapeutics April 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Denali Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Denali Therapeutics shares will generate the highest return on investment. By undertsting and applying Denali Therapeutics stock market strength indicators, traders can identify Denali Therapeutics entry and exit signals to maximize returns
| Accumulation Distribution | 121582.0 | |||
| Daily Balance Of Power | 0.0188 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 28.22 | |||
| Day Typical Price | 28.38 | |||
| Price Action Indicator | 0.49 | |||
| Period Momentum Indicator | (12.09) |
Denali Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Denali Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Denali Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Denali to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0093 | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | (0) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Denali Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.06) | Revenue Per Share 2.406 | Quarterly Revenue Growth (1.00) | Return On Assets (0.09) | Return On Equity (0.14) |
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.